Видео ютуба по тегу Medicines: Natalizumab

What You Need to Know About Natalizumab (Tysabri®)
What You Need to Know About Natalizumab (Tysabri®)
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock
Bench to Bedside: Multiple Sclerosis and Tysabri, Part 1 - Ted Yednock
Benefits of SC natalizumab in MS
Benefits of SC natalizumab in MS
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML
Safely switching from natalizumab to ocrelizumab in patients with MS at risk of PML
Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy
Risk Analysis of Natalizumab in Progressive Multifocal Leukoencephalopathy
Review of Natalizumab for MS
Review of Natalizumab for MS
NEXT-MS trial: natalizumab personalized extended interval dosing
NEXT-MS trial: natalizumab personalized extended interval dosing
Updates on natalizumab and anti-CD20 antibodies for MS
Updates on natalizumab and anti-CD20 antibodies for MS
Additional Insights from Natalizumab Treatment in MS
Additional Insights from Natalizumab Treatment in MS
Extending Natalizumab's Use Without Increasing Risk to Patients
Extending Natalizumab's Use Without Increasing Risk to Patients
Extending Natalizumab's Use Without Increasing Risk to MS Patients
Extending Natalizumab's Use Without Increasing Risk to MS Patients
Analysis of a Phase II Trial of Natalizumab and Steriods as Treatment for High Risk GVHD
Analysis of a Phase II Trial of Natalizumab and Steriods as Treatment for High Risk GVHD
How is Tysabri Used in MS?
How is Tysabri Used in MS?
MS Treatment 2021: We don't treat Multiple Sclerosis correctly.
MS Treatment 2021: We don't treat Multiple Sclerosis correctly.
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
NEXT-MS: personalized extended interval dosing of natalizumab in RRMS
NEXT-MS: personalized extended interval dosing of natalizumab in RRMS
Tysabri and MS - National MS Society
Tysabri and MS - National MS Society
ACTION: Natalizumab Did Not Reduce Infarct Volume
ACTION: Natalizumab Did Not Reduce Infarct Volume
Enhancing convenience and flexibility with SC natalizumab for MS
Enhancing convenience and flexibility with SC natalizumab for MS